Meanwhile, to investigate whether α5-nAChR influenced PD-L1 expression via STAT3-Jab1 signalling in NSCLC, we performed a ChIP assay to identify STAT3 binding to the Jab1 promotor. Here, STAT3 is linked to non-small cell lung carcinoma.